Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-2-21
pubmed:abstractText
We previously reported that hypoxia-mediated reductions in alpha-adrenoceptor sensitivity do not explain the augmented vasodilatation during hypoxic exercise, suggesting an enhanced vasodilator signal. We hypothesized that beta-adrenoceptor activation contributes to augmented hypoxic exercise vasodilatation. Fourteen subjects (age: 29 +/- 2 years) breathed hypoxic gas to titrate arterial O(2) saturation (pulse oximetry) to 80%, while remaining normocapnic via a rebreath system. Brachial artery and antecubital vein catheters were placed in the exercising arm. Under normoxic and hypoxic conditions, baseline and incremental forearm exercise (10% and 20% of maximum) was performed during control (saline), alpha-adrenoceptor inhibition (phentolamine), and combined alpha- and beta-adrenoceptor inhibition (phentolomine/propranolol). Forearm blood flow (FBF), heart rate, blood pressure, minute ventilation, and end-tidal CO(2) were determined. Hypoxia increased heart rate (P < 0.05) and minute ventilation (P < 0.05) at rest and exercise under all drug infusions, whereas mean arterial pressure was unchanged. Arterial adrenaline (P < 0.05) and venous noradrenaline (P < 0.05) were higher with hypoxia during all drug infusions. The change (Delta) in FBF during 10% hypoxic exercise was greater with phentolamine (Delta306 +/- 43 ml min(-1)) vs. saline (Delta169 +/- 30 ml min(-1)) or combined phentolamine/propranolol (Delta213 +/- 25 ml min(-1); P < 0.05 for both). During 20% hypoxic exercise, DeltaFBF was greater with phentalomine (Delta466 +/- 57 ml min(-1); P < 0.05) vs. saline (Delta346 +/- 40 ml min(-1)) but was similar to combined phentolamine/propranolol (Delta450 +/- 43 ml min(-1)). Thus, in the absence of overlying vasoconstriction, the contribution of beta-adrenergic mechanisms to the augmented hypoxic vasodilatation is dependent on exercise intensity.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-10601170, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-10694525, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-10797118, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-11004135, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-11356642, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-11731591, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-12221051, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-12356892, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-12388461, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-12456491, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-12730336, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-1325292, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-1474060, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-16809628, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-16914431, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-17510298, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-2513315, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-2732164, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-2743745, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-3182518, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-4572510, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-6072573, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-6176798, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-6663024, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-7869251, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-8703649, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-8887765, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-9808594, http://linkedlifedata.com/resource/pubmed/commentcorrection/18048452-994038
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1469-7793
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
586
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1195-205
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:18048452-Adult, pubmed-meshheading:18048452-Anoxia, pubmed-meshheading:18048452-Antihypertensive Agents, pubmed-meshheading:18048452-Blood Gas Analysis, pubmed-meshheading:18048452-Blood Pressure, pubmed-meshheading:18048452-Epinephrine, pubmed-meshheading:18048452-Exercise, pubmed-meshheading:18048452-Female, pubmed-meshheading:18048452-Forearm, pubmed-meshheading:18048452-Heart Rate, pubmed-meshheading:18048452-Humans, pubmed-meshheading:18048452-Male, pubmed-meshheading:18048452-Norepinephrine, pubmed-meshheading:18048452-Phentolamine, pubmed-meshheading:18048452-Propranolol, pubmed-meshheading:18048452-Receptors, Adrenergic, beta, pubmed-meshheading:18048452-Regional Blood Flow, pubmed-meshheading:18048452-Vasodilation, pubmed-meshheading:18048452-Vasodilator Agents
pubmed:year
2008
pubmed:articleTitle
Exercise intensity-dependent contribution of beta-adrenergic receptor-mediated vasodilatation in hypoxic humans.
pubmed:affiliation
Department of Human Physiology, 122 Esslinger Hall, 1240 University of Oregon, Eugene, OR 97403-1240, USA. bwilkins@uoregon.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural